About Arcellx, Inc. 
Arcellx, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 65 Schemes (42.04%)
Foreign Institutions
Held by 116 Foreign Institutions (8.7%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Jun 2025)
Net Profit:
-53 Million
Pharmaceuticals & Biotechnology
USD 3,982 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.03
-49.44%
9.03






